Robert G. Shawah, Chief Accounting Officer at Dipexium Pharmaceuticals, Inc. (DPRX), bought 500 shares at $12.00 ($6K) on 2014-03-18, disclosed to the SEC on 2014-03-19.
Open-market purchase of $6k DPRX by Chief Accounting Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.